Uncovering the Molecular Drivers of B-cell Lymphoma Tumor Growth - News CenterA study reveals BAP1's role in regulating tumor growth in B-cell lymphomas, linking it to immune response modulation.
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphomaThe VENTANA Kappa and Lambda Dual ISH assay is the first clinically approved test to identify B-cell lymphoma subtypes with high sensitivity.
Five-drug combination targets aggressive B-cell lymphomasA non-chemotherapy treatment regimen called ViPOR is achieving full remissions for some patients with aggressive B-cell lymphoma. Combination targets multiple molecular pathways crucial for tumor survival.